Eton Pharmaceuticals appoints Danka Radosavljevic as COO

Eton Pharmaceuticals, Inc.

Danka Radosavljevic appointed COO effective July 31, 2026; previously EVP of Operations since 2017.
Annual base salary set at $520,800; discretionary bonus target of 50% of base salary.
Radosavljevic oversaw quality, product development, regulatory, supply chain, and IT in prior role.

item 5.02

Eton Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-025506

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.